Literature DB >> 12503852

Pancreatic Duodenal Homeobox (PDX-1) in health and disease.

Danielle Melloul1, Anat Tsur, David Zangen.   

Abstract

Insulin is expressed exclusively in the adult beta-cells of the islets of Langerhans. Pancreatic Duodenum Homeobox-1 (PDX-1) is a major regulator of transcription in these cells. It transactivates the insulin gene by binding to a specific DNA motif in its promoter region. Glucose, the main physiological regulator of insulin secretion, also regulates insulin gene transcription through PDX-1. While acute exposure to high glucose concentrations causes an increase in PDX-1 binding, and consequently in insulin mRNA levels, chronic hyperglycemia (toxic to the beta-cell) leads to a decrease in PDX-1 and insulin levels. PDX-1 is absolutely required for pancreas development. In view of the selective expression in adult beta-cells, pancreatic agenesis in both the pdx-1 null mouse and a human carrying a homozygous mutation of PDX-1 was an unexpected and remarkable finding. The homozygous clinical phenotype was neonatal diabetes mellitus (DM) and exocrine insufficiency. Heterozygosity for PDX-1 mutations was found in some individuals with a newly characterized subtype of maturity-onset diabetes of the young (MODY4) and in others with type 2 DM. This review underlines the unique role of PDX-1 in maintaining adult beta-cell-specific functions in normal and disease-related states.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12503852     DOI: 10.1515/jpem.2002.15.9.1461

Source DB:  PubMed          Journal:  J Pediatr Endocrinol Metab        ISSN: 0334-018X            Impact factor:   1.634


  8 in total

Review 1.  Defining the cancer master switch.

Authors:  Courtney J Balentine; David H Berger; Shi-He Liu; Changyi Chen; John Nemunaitis; F Charles Brunicardi
Journal:  World J Surg       Date:  2011-08       Impact factor: 3.352

Review 2.  Inherited pancreatic cancer.

Authors:  Fei Chen; Nicholas J Roberts; Alison P Klein
Journal:  Chin Clin Oncol       Date:  2017-12

3.  Human Krüppel-like factor 11 inhibits human proinsulin promoter activity in pancreatic beta cells.

Authors:  X Niu; N Perakakis; K Laubner; C Limbert; T Stahl; M D Brendel; R G Bretzel; J Seufert; G Päth
Journal:  Diabetologia       Date:  2007-05-04       Impact factor: 10.122

Review 4.  Beta-cell failure in the pathogenesis of type 2 diabetes mellitus.

Authors:  Jeanne H Steppel; Edward S Horton
Journal:  Curr Diab Rep       Date:  2004-06       Impact factor: 4.810

Review 5.  Genetics and pathophysiology of neonatal diabetes mellitus.

Authors:  Rochelle N Naylor; Siri Atma W Greeley; Graeme I Bell; Louis H Philipson
Journal:  J Diabetes Investig       Date:  2011-06-05       Impact factor: 4.232

6.  Functional interplay between the transcription factors USF1 and PDX-1 and protein kinase CK2 in pancreatic β-cells.

Authors:  Sarah Spohrer; Rebecca Groß; Lisa Nalbach; Lisa Schwind; Heike Stumpf; Michael D Menger; Emmanuel Ampofo; Mathias Montenarh; Claudia Götz
Journal:  Sci Rep       Date:  2017-11-27       Impact factor: 4.379

Review 7.  Regulatory Mechanisms of Somatostatin Expression.

Authors:  Emmanuel Ampofo; Lisa Nalbach; Michael D Menger; Matthias W Laschke
Journal:  Int J Mol Sci       Date:  2020-06-11       Impact factor: 5.923

Review 8.  Protein Kinase CK2-A Putative Target for the Therapy of Diabetes Mellitus?

Authors:  Emmanuel Ampofo; Lisa Nalbach; Michael D Menger; Mathias Montenarh; Claudia Götz
Journal:  Int J Mol Sci       Date:  2019-09-07       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.